Skip to main content

Advertisement

SpringerLink
Log in

Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Nicolas L, Milon G, Prina E (2002) Rapid differentiation of Old World Leishmania species by LightCycler polymerase chain reaction and melting curve analysis. J Microbiol Methods 51:295–299

    Article  PubMed  CAS  Google Scholar 

  2. Murray HW, Berman JD, Davies CR, Saravia NG (2005) Advances in leishmaniasis. Lancet 366:1561–1577

    Article  PubMed  CAS  Google Scholar 

  3. Fernández-Guerrero ML, Robles P, Rivas P, Mójer F, Muñíz G, de Górgolas M (2004) Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta Trop 90:11–16

    Article  PubMed  Google Scholar 

  4. Basset D, Faraut F, Marty P, Dereure J, Rosenthal E, Mary C, Pratlong F, Lachaud L, Bastien P, Dedet JP (2005) Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature. Microbes Infect 7:1370–1375

    Article  PubMed  Google Scholar 

  5. Pitini V, Cascio A, Arrigo C, Altavilla G (2012) Visceral leishmaniasis after alemtuzumab in a patient with chronic lymphocytic leukaemia. Br J Haematol 156:1

    Article  PubMed  Google Scholar 

  6. Hirai M, Kadowaki N, Kitawaki T, Fujita H, Takaori-Kondo A, Fukui R, Miyake K, Maeda T, Kamihira S, Miyachi Y, Uchiyama T (2011) Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of toll-like receptors and endoplasmic reticulum homeostasis. Blood 117:500–509

    Article  PubMed  CAS  Google Scholar 

  7. Yanaba K, Yoshizaki A, Muroi E, Hara T, Ogawa F, Shimizu K, Sato S (2010) The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses. J Leukoc Biol 88:117–122

    Article  PubMed  CAS  Google Scholar 

  8. Basler M, Lauer C, Beck U, Groettrup M (2009) The proteasome inhibitor bortezomib enhances the susceptibility to viral infection. J Immunol 183:6145–6150

    Article  PubMed  CAS  Google Scholar 

  9. Nucci M, Anaissie E (2009) Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis 49:1211–1225

    Article  PubMed  CAS  Google Scholar 

  10. Chanan-Khan A, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, Neuwirth R, Anderson KC, Richardson PG (2008) Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study. J Clin Oncol 26:4784–4790

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology and Hematology, Azienda Ospedaliera Pugliese-Ciaccio, Viale Pio X, 88100, Catanzaro, Italy

    Eugenio Piro, Mariagrazia Kropp, Renato Cantaffa, Angelo Giuseppe Lamberti, Guido Carillio & Stefano Molica

Authors
  1. Eugenio Piro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mariagrazia Kropp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Renato Cantaffa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Angelo Giuseppe Lamberti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guido Carillio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stefano Molica
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guido Carillio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piro, E., Kropp, M., Cantaffa, R. et al. Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib. Ann Hematol 91, 1827–1828 (2012). https://doi.org/10.1007/s00277-012-1482-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1482-6

Keywords

Search

Navigation